Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

XOMA Corp (NASDAQ:XOMA)

33.15
Delayed Data
As of Jan 18
 +0.52 / +1.59%
Today’s Change
3.96
Today|||52-Week Range
37.25
-6.88%
Year-to-Date

Today’s Trading

Previous close32.63
Today’s open33.19
Day’s range32.20 - 33.75
Volume124,387
Average volume (3 months)193,186
Market cap$265.7M
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-161.47%
Earnings growth (this year)+106.45%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-89.97%
P/E ratioNM
Price/Sales4.57
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...-0.07-0.61%
AGTCApplied Genetic Tech...+0.05+1.27%
NNVCNanoViricides Inc+0.03+3.29%
CRMECardiome Pharma Corp-0.01-0.39%
Data as of 8:00pm ET, 01/18/2018

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$5.6M
Annual profit (last year)-$53.5M
Net profit margin-962.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James R. Neal
CFO, Principal Accounting Officer &
VP-Finance
Thomas Burns
Corporate headquarters
Berkeley, California

Forecasts